Research Article

Clinical Outcomes from Unselected “Real-World” Patients with Long Coronary Lesion Receiving 40 mm Biodegradable Polymer Coated Sirolimus-Eluting Stent

Table 3

Cumulative clinical outcomes up to 6 months.

In hospital (; 100%)30-day follow-up (; 100%)6-month follow-up (; 99.22%)

Death, (%)2 (0.8%)2 (0.8%)2 (0.8%)
 Cardiac death, (%)2 (0.8%)2 (0.8%)2 (0.8%)
 Noncardiac death, (%)0 (0%)0 (0%)0 (0%)
Myocardial infarction, (%) 0 (0%)0 (0%)3 (1.2%)
 Q-wave, (%)0 (0%)0 (0%)2 (0.8%)
 Non-Q-wave, (%)0 (0%)0 (0%)1 (0.4%)
TLR, (%)0 (0%)0 (0%)0 (0%)
TVR, (%)0 (0%)0 (0%)0 (0%)
ST, (%)0 (0%)0 (0%)0 (0%)
Total2 (0.8%)2 (0.8%)5 (2.0%)

TVR: target vessel revascularization; TLR: target lesion revascularization; ST: stent thrombosis.